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ABSTRACT  
The liver expresses batteries of cytoprotective genes that confer cellular resistance to 
oxidative stress and xenobiotic toxins, and protection against cancer and other stress-related 
diseases. These genes are mainly regulated by Nrf2, making this transcription factor a target for 
small molecule discovery to treat such diseases. In this report, we identified dietary polyphenolic 
antioxidants that not only activated these genes but also relieved Nrf2 repression by Keap1, a Cul3-
dependent ubiquitin ligase adaptor protein that mediates its degradation. Analysis of postprandial 
liver RNA revealed a marked activation of both genes by all test polyphenols compared with 
controls. Nrf2 inhibition by RNA interference reduced polyphenol effects on its target gene 
expression. Our data suggest that polyphenols may induce cellular defense genes by derepressing 
Nrf2 inhibition by Keap1. We posit that this ability to derepress Nrf2 and reactivate its target genes 
may underlie the protection conferred by polyphenols against oxidative stress-related diseases. 
 
Keywords: Antioxidant; antioxidant response element; detoxification; dietary polyphenols; 
cytoprotection. 
 
1. Introduction 
Oxidative and xenobiotic stresses cause a range of diseases through the production of 
reactive oxygen species. In response to these stresses, the liver expresses multidinous cytoprotective 
proteins most of which act as antioxidants or detoxification systems [1]. Archetypal enzymes/genes 
of this stress-response pathway include GST, QR1, and γ-glutamylcysteine synthetase. In response 
to a spectrum of chemical agents including diphenols, quinones, isothiocyanates and heavy metals, 
these genes are activated by Nrf2 [1, 2]. While endogenous antioxidant systems e.g. thioredoxin can 
counter redox stress, there is strong evidence that dietary polyphenols also modify the redox stress 
responses through Nrf2, possibly in synergy with the aryl hydrocarbon receptor [1, 3]. These 
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compounds are therefore of immense interest as therapeutics against cancer, cardiovascular and 
inflammatory diseases [4].  
The current working model of Nrf2 post-translational redox regulation posits that under 
basal (unstressed) conditions, it is sequestered in the cytoplasm by Keap1, a Cul3-dependent 
ubiquitin ligase adaptor protein that targets Nrf2 for ubiquitination and proteasomal degradation [5]. 
Oxidative stress and electrophiles inhibit this process allowing Nrf2 to translocate to the nucleus 
where it dimerizes with the small Maf proteins; the heterodimers then bind to the antioxidant 
response elements (AREs) of Nrf2 target genes to initiate their transcription. The core sequence of 
the ARE is TGACnnnGC (where n is any nucleotide); mutations within the TGAC and/or GC boxes 
attenuate antioxidant-dependent gene expression [2,6]. The ARE is also found in genes involved in 
processes as diverse as iron metabolism, inflammation, and wound healing [7-10].  These genes 
synergistically constitute the main defences against both biotic and abiotic stresses. Consequently, 
Nrf2 knock-out mice are unable to resist oxidative or xenobiotic stress or detoxify drugs, and are 
susceptible to carcinogenesis and autoimmune inflammatory diseases [11-13]. However, mutations 
in Keap1 that reduce its Nrf2-binding capacity and repressivity can also lead (paradoxically) to 
disease through unrestrained Nrf2 expression [14-17]. Keap1 overexpression has also been 
associated with poor prognosis in renal cell carcinoma; increased expression thioredoxin improved 
prognosis [18]. This strongly suggests that constitutive repression of Nrf2 by Keap1 may lead to 
diminished cytoprotection against the disease. Thus inducing a redox shift in favour of Nrf2 
derepression from Keap1 could conceptually reactivate Nrf2-target genes to prevent disease. This 
provided the rationale for this study: to identify small molecules that would reactivate Nrf2-target 
genes that are repressed by Keap1. We screened a small library of dietary polyphenols for their 
potential to: (a) induce Nrf2-target gene expression and, (b) derepress these genes when they are 
transcriptionally-silenced by Keap1. Our findings indicate that the ability of polyphenols to protect 
against disease may be coupled to their ability to derepress Nrf2 from Keap1.   
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2. Materials and methods 
2.1 Reagents.  
2.2 A small library of polyphenols (Table 1) was purchased from Sigma (Poole, UK). This 
included quercetin, kaempferol, caffeic acid, rutin, resveratrol, ferulic acid, luteolin, naringenin, 
epicatechin, (-)-epigallocatechin-3-gallate (EGCG), sulforaphane and tert butylhydroquinone. The 
compounds were dissolved in DMSO as 100 mM stock solutions. All other analytical grade 
chemicals were also obtained from Sigma. 
 
2.2 Plasmid constructs.  
The human QR1 promoter (750bp) was amplified from human genomic DNA with the 
primers: CATGCTAGCACCTGCCTTGAGGAGCAGG (hQR1P-S) and 
CATGCTCGAGAGCACTCACCGACCATGG (hQR1P-A). Primers were derived from Accession 
number M81596 [19]. The PCR product was restricted with NheI and XhoI (sites underlined), and 
ligated into the same sites in pGL3Basic vector (Promega) to generate hQR1Pluc. The mutant 
promoter vector hQR1PlucΔARE lacking the ARE, was generated by site-directed mutagenesis 
with the QuikChange mutagenesis kit (Stratagene).  
For ARE-luciferase enhancer constructs, the following phosphorylated primers containing 
the AREs (bold-face) were synthesized (MWG Biotech): rQR1-ARE sense, 
CTAGCGAATTCAGTCTAGAGTCACAGTGACTTGGCAAAATCTGAC; rGST-Ya ARE sense, 
CTAGCGAATTCTGGAAATGGCATTGCTAATGGTGACAAAGCAACC. Mutant QR1-ARE 
oligonucleotides were also synthesized as follows: AREMt sense, 
CTAGCGAATTCAGTCTAGAGTCACAGTaACTTGaCAAAATCTGAC. Oligonucleotides were 
annealed [20] and ligated directionally into the NheI-XhoI sites of the pGL3 Promoter vector 
(Promega). Recombinant plasmids were verified by linearization at unique EcoRI sites within the 
oligonucleotides. The resulting constructs were labeled QR-ARELuc, GST-ARELuc and ARE-
MtLuc respectively. All plasmids were sequenced (MWG Biotech) for verification. 
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2.3 Cell culture, transfection and reporter assays.  
HepG2 cells (ECACC, UK) were cultured in 10 cm dishes in Minimum Essential Medium 
with Earle’s salts supplemented with non-essential amino acids, L-glutamine, 10% FBS, antibiotics 
and antimycotics (Invitrogen). Cells were transfected at 80% confluence with 10 µg of ARE-Luc 
constructs and 1 µg pSVβgal (Promega) as internal control, using FuGENE 6 (Roche) according to 
the manufacturer’s instructions. After 18 h, the cells were trypsinized, centrifuged, resuspended in 
fresh medium and distributed into 24-well plates (Corning); they were treated with various 
polyphenols or with DMSO (solvent control) for 24 h. For transactivation or repression, cells were 
seeded in 24-well plates and cotransfected with 100 ng ARE-Luc constructs and 100 ng Nrf2 alone 
or together with 100 ng Keap1 expression plasmids respectively; 50 ng pSVβgal was included as 
internal control. The cells were then treated with DMSO or with selected polyphenols for 24 h. 
Analysis of reporter gene expression was as previously described [20].  
 
2.4 Nrf2 knock-down.   
A retroviral vector (pRS-hNrf2) expressing short-hairpin RNA to human Nrf2 was used to 
transfect Hep3B cells with 5 µg /10 cm dish using Fugene HD (Roche). In parallel, cells were 
transfected with the negative control vector pRS-GFP. After 48 h, the medium was replaced and 
supplemented with 2 µg/ml puromycin (Sigma). Stable cell lines were established after 3 weeks of 
continuous selection. Both cell lines were transfected with hQR1Pluc and pSVβgal, and then treated 
with polyphenols as described above. 
 
2.5 Expression and purification of recombinant Nrf2 and MafG.  
pET15b-Nrf2 and pET15b-MafG plasmids were transformed into BL21-CodonPlus (DE3)-
RIPL cells (Stratagene) and induced with 0.4 mM IPTG for 3 h at 37
o
C. Recombinant His-Nrf2 and 
His-MafG were purified using the MagneHis Protein Purification kit (Promega) as recommended by 
the manufacturer. 
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2.6 Analysis of phase II gene activation in vivo by polyphenols.  
Animals were handled according to UCL institutional guidelines approved by the UK Home 
Office. Male Sprague-Dawley rats (230-290 g), maintained ad libidum on standard rat chow (Diet 
RM1, United Kingdom), were gavage-fed with 50 mg/kg body weight of kaempferol, naringenin, 
quercetin and resveratrol dissolved in 1 ml of 10% DMSO/50% ethanol in normal saline; control 
animals were gavage-fed with 1 ml of carrier solvent. After 18 h, the rats were anaesthetised with 
pentobarbitone sodium (90 mg/kg, i.p.) and the livers were removed into RNAlater (Ambion). Total 
RNA was extracted using the Qiagen RNeasy kit (Qiagen). Two parallel Northern blots of RNA (10 
µg) resolved on a 1% formaldehyde gel and transferred onto Hybond N+ membrane (Amersham 
Biosciences) were pre-hybridized in UltraHyb buffer (Ambion) for 30 min at 42
o
C. The blots were 
then hybridized overnight in the same buffer at 42
o
C with complementary oligonucleotide probes to 
rat QR1 (CTCTCTGCGTGGGCCAATACAATCAGGGCTCTTCTCACCGCCAT) or rat GST-Ya 
(TGCCCCGGGCATTGAAGTAGTGAAGCACTGGCTTCCCAGACAT), end-labeled with [γ-
32
P] ATP. Post-hybridization washes were performed with 3X 15 min in SSC/0.1% SDS and then 
for 30 min at 60
o
C in 0.1X SSC/0.1% SDS. The blots were exposed to Kodak X-omat film (Sigma) 
overnight at -80 
o
C. 
 
2.7 Electrophoretic mobility shift assay (EMSA).  
HepG2 cells were treated with 100 µM selected polyphenols or with DMSO (0.1% final 
concentration) for 6 h. Nuclear extracts were prepared and mobility shift assays were performed as 
previously described [20], using duplex ARE oligonucleotides (described above) end-labeled with 
γ-32P[ATP]. For competition, unlabeled probe was added in molar excess (100 pmols) to the 
extract for 10 min before adding the radiolabeled probe. To confirm binding specificity, His-Nrf2 
and His-MafG were incubated with the ARE probes as homodimers or heterodimers. Binding 
reactions were resolved and processed as described previously [20]. 
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2.8. Western blotting.  
Nuclear extracts were prepared from the livers of rats treated as above. Approximately 10 
µg of the extracts were resolved on 4-12% NUPAGE Novex Bis-Tris gels using MES-SDS running 
buffer (Invitrogen). Proteins were and transferred to Immobilon-P membranes (Millipore). The blot 
was blocked for 1 h at room temperature in Tris-buffered saline/0.5% Tween 20 (TBST) containing 
5% non-fat milk, and then incubated at 4
o
C overnight with anti-Nrf2 antibody (R & D Systems; cat 
# MAB3925). The membrane was washed 3X 5 min with TBST and incubated with goat anti-rabbit 
IgG HRP-conjugate (Sigma). Nrf2 was detected using the Visualizer Western blotting kit 
(Millipore) in a LAS-1000 Image Reader (Fujifilm) set for chemiluminescence detection. The 
membrane was stripped and re-probed with an HRP-conjugated anti-actin antibody (Abcam) to 
ascertain equivalent protein loading. 
 
2.9 Chromatin immunoprecipitation assay.  
To determine Nrf2 recruitment to the hQR1 promoter within its genomic context, HepG2 
cells were either treated with either DMSO or with polyphenols for 6 h. Following  formaldehyde 
cross-linking, chromatin was isolated and precipitated with 10 µg of the above Nrf2 antibody, using 
a chromatin immunoprecipitation assay kit (Upstate Biotechnology) as instructed by the 
manufacturer. The immune complexes were eluted and DNA was purified by phenol-chloroform 
extraction and ethanol-precipitation as previously described [20]. For PCR, primers hQR1P-S 
(above) and GGCTGCAGCTCCAGGAAGGGAG were used to amplify a 500bp fragment of the 
hQR1 promoter over 35 cycles; PCR products were resolved on a 2% agarose gel in 1X TAE.  
 
2.10 Statistical analysis.  
Data analyses were performed and graphs were plotted with the GraphPad Prism software 
(GraphPad Software). Statistical significance was determined by the Mann-Whitney U test or the 
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one-way analysis of variance (ANOVA)/Student-Newman-Keuls multiple-comparisons test where 
applicable. Probability (P) values < 0.05 were accepted as significant.  
 
3. Results  
3.1 Differential activation of phase 2 genes from cognate AREs by polyphenols.  
We set out to identify natural small molecule Nrf2 activators that would induce 
cytoprotective genes. Reporter vectors of the cognate AREs (and mutants) of two archetypal 
cytoprotective genes QR1 and GST-Ya (Fig. 1A) were transfected into HepG2 cells which were 
then treated with a selection of dietary polyphenols or with DMSO. Reporter assays showed that the 
AREs were functionally sufficient in driving basal luciferase expression. Treatment of the 
transfected cells with various polyphenols showed that compared with DMSO, these compounds 
enhanced luciferase expression several-fold from wild-type but not from mutant ARE constructs 
(Fig. 1B, C). Based on these data, we could stratify these compounds by the level to which they 
could induce ARE-mediated luciferase expression. Potent inducers were the flavonols quercetin, 
naringenin and kaempferol, while the tea-derived catechin EGCG, which belongs to the flavan 
group of polyphenols, was a poor inducer. While both core ARE elements in the enhancer 
constructs are conserved the activation profiles for both QR1 and GST-Ya were similar but not 
identical; they elicited some differences in luciferase expression suggesting that sequences 
juxtaposing the cognate core AREs may be important [10]. This was manifested by Nrf2 co-
expression with the cognate AREs (Fig. 1D). To test the ARE in a larger genomic context, we 
cloned ~750bp of the human QR1 promoter; the ARE was mutated by site-directed mutagenesis. 
Luciferase assays revealed that Nrf2 transactivated wild-type full-length hQR1luc but not its ARE 
mutant (Fig. 1E), confirming the crucial role of the ARE in phase II gene expression.  
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3.2 Transcriptional derepression of Nrf2 from Keap1 by polyphenols.  
To establish whether polyphenols could reactivate Keap1-silenced genes, we first co-
transfected hQR1luc with increasing concentrations of Keap1 into HepG2 cells; we found a dose-
dependent repression of Nrf2 transactivation of promoter activity by Keap1 (Fig. 2A). Intriguingly, 
this repression was completely reversed by polyphenol treatment (Fig. 2B). In similar experiments 
with the ARE enhancer constructs, we observed that Keap1 co-expression reduced ARE 
transactivation by Nrf2 but this was also completely reversed when cells were treated with 
polyphenols (Fig. 2C, D). This suggests that polyphenols may confer cytoprotection by Nrf2 
transcriptional derepression from Keap1. To further confirm the role of Nrf2 in polyphenol-
dependent gene activation, we generated a hepatoma cell line that constitutively expressed short 
hairpin RNAs that target Nrf2. Transfection of these cells with hQR1luc and treatment with 
polyphenols revealed a 60% reduction in ARE responsiveness compared with cells expressing 
control short hairpin RNA against GFP (Fig. 2E).  
 
3.3 Recruitment of Nrf2 to AREs in vitro and in vivo.  
To further confirm that Nrf2 was induced and recruited to the AREs by polyphenol 
treatment, we performed EMSA. Nuclear extracts were prepared from HepG2 cells treated with a 
selection of polyphenols while control cells were treated with DMSO.  Mobility shift showed that 
while the mutant ARE was unable to bind, we found specific binding to wild-type AREs by nuclear 
proteins from polyphenol-treated cells compared with DMSO-treated cells (Fig. 3A, B). Specific 
binding was ascertained by inclusion of a 100-fold molar excess of the cold ARE probe; this 
showed competitive inhibition of binding by radiolabeled ARE. EMSA with recombinant Nrf2 and 
MafG also showed that MafG-Nrf2 heterodimers bound strongly to the ARE; this binding showed 
Nrf2 concentration-dependence (Fig. 3C, D). Finally, ChIP assays with an Nrf2-specific antibody 
showed that compared with DMSO, polyphenols induced Nrf2 recruitment to the AREs in HepG2 
cells (Fig. 3E). 
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3.4 In vivo induction of phase 2 genes by polyphenols.  
In order to study the in vivo effects of polyphenols on phase II gene expression, age-matched 
rats were gavage-fed for 18 h with kaempferol, naringenin, quercetin and resveratrol; control 
animals were gavage-fed with DMSO in normal saline. Northern blotting of liver RNA revealed a 
marked up-regulation in both QR1 and GST-Ya expression in rats fed with polyphenols compared 
with DMSO-fed controls (Fig. 4A). Densitometric scans of QR1 and GST-Ya transcripts on the blot 
showed differences in gene expression induced by the polyphenols; their potencies were in the 
order: quercetin > resveratrol > naringenin > kaempferol. To test whether these compounds induced 
Nrf2 in vivo, we performed Western blotting on rat liver cell nuclear extracts. We found increased 
Nrf2 protein levels, with resveratrol and quercetin being better inducers than naringenin and 
kaempferol (Fig. 4B). 
 
4. Discussion 
Our study was predicated on finding natural small molecules that could modify the 
dynamics of Nrf2-Keap1 interaction. We focused on dietary polyphenols because although several 
studies have supported their involvement in cellular defense against oxidative stress [21], the 
molecular basis of their chemoprotective potential is only partially understood. We chose QR1 and 
GST-Ya as exemplars of Nrf2 target genes because they have been shown to be integral to body 
defenses against environmental toxins, oxidative stress-induced cell death and carcinogenesis [22, 
23]. We therefore developed a surrogate system using the AREs of QR1 and GST-Ya fused to the 
luciferase gene. Reporter assays showed that polyphenols differ in their abilities to induce gene 
expression. The flavonols (e.g. kaempferol) were potent in transcriptional activation of ARE-
dependent reporter expression while the tea flavan EGCG was not active in vitro. This therefore 
suggests that polyphenol stereochemistry may determine their relative antioxidant potentials and 
therefore their capacity for Nrf2-target gene activation. These potencies were reflected in post-
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prandial liver RNA analysis which showed that rats fed polyphenols showed differential phase II 
gene induction; compared with DMSO, all the compounds tested increased QR1 and GST-Ya 
mRNA levels, with quercetin inducing the highest expression levels.  
Although largely regarded as antioxidants, most polyphenols have (residual) pro-oxidant 
activity due to their ability to generate free hydroxyl radicals (oxidative stress) especially in the 
presence of transition metals including copper and iron [24]. Oxidative stress and electrophiles 
induce cysteine modifications in Keap1, enabling Nrf2 to activate its battery of defense genes [2, 
25]. Our experiments were therefore designed to assess how dietary polyphenols affect the Nrf2-
Keap1 dynamics. We found up-regulation of ARE-luciferase activity with Nrf2 while Nrf2 
knockdown or ARE deletion reduced gene inducibility by polyphenols. These experiments suggest 
that the ARE might serve as a regulatory node for Nrf2-target gene repression-derepression cycles. 
Although Keap1 repressed Nrf2, this repression could be completely reversed by polyphenols 
suggesting that these compounds may modify the dynamics of the Nrf2-Keap1 interaction in vivo to 
ensure cytoprotective gene transcription. Thus we envision a mechanism where the proportion of 
transcriptionally active Nrf2-target genes could be determined by diet. Our findings therefore 
improve our understanding of how polyphenols may differentially affect gene expression and 
human health through their ability to derepress Nrf2 and its target genes that are silenced by Keap1. 
We suggest that this ability may underlie the “French paradox”, i.e. the low incidence of coronary 
heart disease in some regions (e.g. Mediterranean) despite a relatively high intake of foods rich in 
saturated fat [26]. In those regions, diets are rich in fruits and vegetables, indicating that 
polyphenol-rich diets may have a direct role in disease prevention. However it is also speculated 
that the French paradox may be attributed to the ability of some polyphenols such as resveratrol to 
mimic the oestrogen receptor (ER) ligand oestradiol and to activate ER signaling [27]. 
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Figures and Table legends 
Table 1 
List of polyphenols used in this study. All were used in vitro but where indicated the dosages of 
compounds used in vivo are shown. 
 
Fig.1. Screening of dietary polyphenols for Nrf2 pathway activation. (A) Schematic of plasmid 
reporter constructs. The human QR1 promoter hQR1Pluc (Wt and ARE mutant constructs); the 
transcription start site (+1) and nucleotide positioning is based on ref. 23. Mutations within the 
TGAC and GC boxes are shown. A putative AP1 site within the ARE is underlined. Lower panel: 
Enhancer constructs derived from the AREs of QR1 and GST-Ya in transcriptional fusions with the 
minimal SV40 early promoter and luciferase gene to generate QR-AREluc and GST-AREluc 
respectively. ARE-Mtluc is QR-AREluc with mutations in the TGAC and GC boxes. Arrow 
indicates direction of transcription. (B). Differential activation of ARE-dependent luciferase 
expression by polyphenols. HepG2 cells were transfected with QR-ARELuc or GST-ARELuc and 
treated with 50 µM polyphenols including tBHQ. Luciferase activity was normalized to β-
galactosidase levels. pGL3 Promoter vector backbone and ARE-Mtluc were included for 
comparison. Fold activation is a ratio of luciferase expression from polyphenol-treated verses 
DMSO-treated cells. Values are averages of 4 independent transfections. (C) ARE-luc and mutant 
constructs were transfected alone (filled bars) or with Nrf2 expression plasmid (stippled bars) into 
HepG2 cells. (D) QR1 regulation by Nrf2 is ARE-dependent. Full-length promoter and its ARE 
mutant were co-transfected with Nrf2. Fold activation is a ratio of  luciferase expression  and basal 
pGL3 Promoter vector activity with and without Nrf2. Data represent means of 3 independent 
transfections ± S.E.M. *, P value < 0.05.  
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Fig. 2 Polyphenols induce Nrf2 transcriptional derepression from Keap1. (A) hQR1Pluc was 
transfected into HepG2 without or with Nrf2 and increasing concentrations of Keap1. (B) 
Polyphenols prevent Nrf2 target gene-silencing by Keap1. hQR1Pluc was cotransfected with Nrf2 
and Keap1; cells were treated with DMSO or polyphenols. (C, D) Transcriptional derepression of 
Nrf2 by dietary polyphenols. QR-ARELuc and GST-ARELuc were transfected into HepG2 cells 
alone or in combination with 100 ng Nrf2. Where indicated, Keap1 was co-transfected and treated 
with 100 μM polyphenols. (E) Nrf2 knockdown diminishes inducibility by polyphenols. Hep3B 
cells expressing short-hairpin Nrf2 RNA were transfected with 100 ng hQR1Pluc and treated with 
DMSO or polyphenols for 24 h. Luciferase activities were determined for 3 independent 
replications of the experiment; all values are averages of these replications ± S.E.M.  
 
Fig. 3 Polyphenols induce Nrf2 binding to the antioxidant response elements in vitro and in 
vivo. Nuclear extracts from HepG2 cells treated with either DMSO or polyphenols were incubated 
with (A) GST-Ya ARE or (B) QR-ARE. Lane designations: 1, ARE oligo only or with nuclear 
extracts from cells treated with: 2, DMSO; 3, kaempferol; 4, naringenin; 5, quercetin; 6, resveratrol; 
7, sulforaphane (20 µM); 8, 100µM tBHQ; 9, kaempferol-treated nuclear extracts incubated with 
mutant ARE or 10, with 100-fold molar excess of unlabeled ARE probe Arrow indicates ARE-
nucleoprotein complex. (C, D) ARE-binding specificity. Recombinant MafG or Nrf2 were 
incubated with ARE alone (lanes 3 and 4 respectively), or with MafG and increasing concentrations 
of Nrf2. MafG-Nrf2 heterodimers are indicated with arrows. Competitor probes (cold or mutant 
ARE) were included as indicated. ARE probe alone (lane 1) or purified GST (lane 2) are negative 
controls. (E) Chromatin immunoprecipitation assay. HepG2 cells were treated with 100µM 
kaempferol, naringenin, quercetin, and DMSO. Chromatin was immunoprecipitated with anti-Nrf2 
antibody or without antibody. A 500 bp fragment of the QR1 promoter was amplified by PCR from 
10% of the eluted chromatin. Non-immunoprecipitated chromatin was used as (Input) positive 
control.  
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Fig. 4 Dietary polyphenols induce Nrf2 pathway genes. (A). In vivo activation of QR1 and GST-
Ya by dietary polyphenols. Two Northern blots of liver RNA isolated from rats fed DMSO, 
kaempferol, naringenin, quercetin, and resveratrol were probed separately with QR1 (top panel) or 
GST-Ya (middle panel) oligonucleotide probes. Bottom panel is an ethidium bromide-stained 
denaturing agarose gel of ribosomal RNA (rRNA) to ascertain equivalent RNA loading. (B) 
Western blotting. Rat liver cell nuclear extracts from the above treatments were probed for Nrf2 
expression; β-actin was used as internal control. 
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